Genus plc
From Wikipedia, the free encyclopedia
 |
|
| Public | |
| Traded as | LSE: GNS |
| Industry | Biotechnology |
| Founded | 1933 |
| Headquarters | Basingstoke, Hampshire, UK |
|
Key people
|
Bob Lawson, Chairman[1] Karim Bitar, CEO[1] |
| Revenue | £388.3 million (2016)[2] |
| £58.6 million (2016)[2] | |
| £50.3 million (2016)[2] | |
| Website | www |
Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History[edit]
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
Board of Directors[edit]
- Bob Lawson (Chairman)[1]
- Karim Bitar (CEO)
- Stephen Wilson (Group Finance Director)
- Nigel Turner (Senior Non-Executive Director)
- Mike Buzzacott (Non-Executive Director)
- Professor Duncan Maskell (Non-Executive Director)
- Lykele van der Broek (Non-Executive Director)
- Dan Hartley (Group General Counsel & Company Secretary)
Operations[edit]
The Company has two divisions:
References[edit]
- ^ a b c "Genus plc - Investor Relations - Genus Board". genusplc.com. Retrieved 28 March 2015.
- ^ a b c "Preliminary Results 2016" (PDF). Genus plc. Retrieved 21 April 2017.
- ^ The BSE Inquiry
- ^ ABS Global Parent Reports Positive Year-End Results and Stock Listing
- ^ "Genus Completes Acquisition Of Sygen". The Pig Site. Retrieved 28 March 2015.
External links[edit]
| companies |
|
||||
|---|---|---|---|---|---|
| government and regulatory bodies |
|
||||
| industry and professional bodies |
|
||||
| books and journals | |||||
| other | |||||
|
